CN109678739A - A kind of synthetic method of R-3- chlorine serine methyl ester hydrochloride - Google Patents

A kind of synthetic method of R-3- chlorine serine methyl ester hydrochloride Download PDF

Info

Publication number
CN109678739A
CN109678739A CN201811613850.3A CN201811613850A CN109678739A CN 109678739 A CN109678739 A CN 109678739A CN 201811613850 A CN201811613850 A CN 201811613850A CN 109678739 A CN109678739 A CN 109678739A
Authority
CN
China
Prior art keywords
chlorine
methyl ester
ester hydrochloride
ser
serine methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201811613850.3A
Other languages
Chinese (zh)
Other versions
CN109678739B (en
Inventor
王丹
杨文�
李军
张新伟
刘丽莉
袁志法
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Fusheng Jiahua International Trade Co Ltd
Original Assignee
Beijing Fusheng Jiahua International Trade Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Fusheng Jiahua International Trade Co Ltd filed Critical Beijing Fusheng Jiahua International Trade Co Ltd
Priority to CN201811613850.3A priority Critical patent/CN109678739B/en
Publication of CN109678739A publication Critical patent/CN109678739A/en
Priority to PCT/CN2019/103059 priority patent/WO2020134137A1/en
Application granted granted Critical
Publication of CN109678739B publication Critical patent/CN109678739B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/16Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38Separation; Purification; Stabilisation; Use of additives

Abstract

The invention belongs to pharmaceutical synthesis fields, disclose a kind of synthetic method of R-3- chlorine serine methyl ester hydrochloride: by D-Ser, paraformaldehyde, room temperature reaction are added, small size crystallizes to obtain D-Ser NCA;In methyl alcohol, thionyl chloride is added in D-Ser NCA, after room temperature reaction, petroleum ether is added and obtains R-3- chlorine serine methyl ester hydrochloride.This method technological operation is simple, environmental-friendly, and reaction condition is mild, and final products purity is up to 99%, and yield is up to 94.72%, is conducive to industrialized production.

Description

A kind of synthetic method of R-3- chlorine serine methyl ester hydrochloride
Technical field
Invention is related to pharmaceutical synthesis field, is related to a kind of preparation method of R-3- chlorine serine methyl ester hydrochloride.
Background technique
Antibiotic is produced in life process by microorganism (including bacterium, fungi, actinomyces) or high animals and plants Raw has antipathogen or other active-class secondary metabolites, can interfere the chemistry of other living cells development functions Substance.Existing clinically used antibiosis is known as transgenic engineered bacteria, extract and chemically synthesis or half in culture solution liquid The compound of synthesis.Seromycin also known as D-4- amino -3- oxazolidone, are a kind of antibiotics, are had to tubercle bacillus There is good inhibiting effect.Because bacterium is not likely to produce drug resistance to it, drug resistance tubercle bacillus clinically mainly used for treating Infection.In addition the study found that D-Cycloserine is excitatory amino acid NMDA (N-methyl-D- in central nervous system Aspartate) a kind of special regulatory factor of receptor, to psychological diseases such as the psychological neurosis for the treatment of, depression, schizophrenia Disease also has good auxiliary curative effect, while it is also the important centre for synthesizing atypia beta-Lactam antibiotic Lactivicin Body.Therefore, D-Cycloserine is with a wide range of applications and great market demand.
The synthetic route of existing seromycin is mainly synthesized by following route:
Synthetic route following (US2772280, US2772281, US2640565, US2794022, US2918472 and circumfili The research West China Journal of Pharmaceutical Sciences of propylhomoserin chemical synthesis process, 1995,10 (1): 39~39): route steps are long, also need to split, Synthesis cost is higher.
GB 1031267 is reported using β-(α '-ethoxyethylidene) alpha-brominated methyl propionate of-imido oxygen-as raw material D- The preparation method of seromycin.The alpha-brominated methyl propionate of β-(α '-ethoxyethylidene)-imido oxygen-amine under the action of liquefied ammonia Metaplasia is at β-(α '-ethoxyethylidene)-imido oxygen-alanyl amine, then by obtaining β-azyloxy after HCl gas treatment Alanimamides dihydrochloride, then cyclization generates DL- seromycin under the action of KOH, finally splits to obtain D- circumfili with tartaric acid Propylhomoserin.This preparation method expensive raw material price is not easy to obtain, and production cost is higher, is not suitable for industrialized production.
GB854922 is reported using D-1- trityl group ethylene imine -2- methyl formate as the preparation of raw material D-Cycloserine Method.D-1- trityl group ethylene imine -2- methyl formate is first reacted with hydroxylamine hydrochloride at room temperature generates D-1- triphenyl Methylaziridine -2- hydroxamic acid, then open loop generates D- pantonine-chloro propyl hydroxamic acid under the effect of HCl gas Hydrochloride, then D- seromycin is made in cyclization under strong-base anion-exchange resin effect.This preparation method reaction time compared with It is long, and the preparation of raw material D-1- trityl group ethylene imine -2- methyl formate is difficult, is unfavorable for being mass produced.
Etc. PlttenerP.A. propose using D-Ser methyl ester hydrochloride as raw material and synthesize the simple of D-Cycloserine Method.I.e. propylhomoserin first in chlorination generation D-2- amino -3- chlorine occurs for the intoxicated hydrochloride of D-Ser first (1) and phosphorus pentachloride Ester hydrochloride (II), II generate D circumfili nitronic acid (I) with azanol cyclization in sodium hydroxide solution, and cyclization yield is 40%.Synthesis Route is shown below:
The method raw material has used more expensive D-Ser methyl ester hydrochloride, and cost is excessively high, and big in production process Amount uses not tractable PCl5, causes the serious pollution of environment.
R-3- chlorine serine methyl ester hydrochloride is an important intermediate of seromycin, both at home and abroad to R-3- chlorine silk The synthesis of propylhomoserin methyl ester hydrochloride does not have been reported that temporarily.In order to overcome expensive starting materials, the purity of existing D seromycin synthetic technology It is not high, yield is relatively low, deficiency not environmentally, present applicant proposes a new R-3- chlorine serine methyl ester hydrochloride routes, instead It should be routine operation, it is easy to operate;And raw material be all it is commercially available, price is suitable and in liberal supply, there is preferable industrial prospect.
Summary of the invention
Technical problems based on background technology, the invention proposes a kind of R-3- chlorine serine methyl ester hydrochlorides, should Method is at low cost, and environmental pressure is small, and yield is high, is conducive to large-scale production.
A kind of synthetic method of R-3- chlorine serine methyl ester hydrochloride, which is characterized in that method and step is as follows:
1) synthesis of D-Ser-N- carboxy acid anhydride: being added paraformaldehyde for D-Ser in a solvent, room temperature reaction 0.5-3 hours, recycling design crystallized to obtain D-Ser-N- carboxy acid anhydride (D-Ser NCA) to small size;
2) synthesis of R-3- chlorine serine methyl ester hydrochloride: D-Ser NCA is added in a solvent, and thionyl chloride is added, 15-25 DEG C reaction 1-3 hours, after recycling design, be added petroleum ether crystallize to obtain R-3- chlorine serine methyl ester hydrochloride.
Preferably, the molar ratio of D-Ser and paraformaldehyde is 1:1.2-1.5 in the reaction.
Preferably, the molar ratio of D-Ser NCA and thionyl chloride and petroleum ether is 1:1.5-2.0 in the reaction: 1。
Preferably, the step 1) solvent is anhydrous tetrahydro furan or methylene chloride.
Preferably, the step 2) solvent is methanol or ethyl alcohol.
Synthetic route of the invention is as follows:
(1)
(2)
Compared with prior art, the device have the advantages that being:
R-3- chlorine serine methyl ester hydrochloride is an important intermediate of seromycin, both at home and abroad to R-3- chlorine silk The synthesis of propylhomoserin methyl ester hydrochloride does not have been reported that temporarily, since hydroxyl is not easy to be substituted during cyclization, so the prior art is not Use the intermediate.Compared to the synthetic intermediate of existing seromycin, the invention proposes a kind of R-3- chlorine serine methylester salt The synthetic method of hydrochlorate forms NCA in step 1), and hydroxyl is easier to be substituted, and R-3- chlorine serine methyl ester hydrochloride is easily made It is standby, to obtain higher yield, it is suitble to industrialized production, purity is high has direct influence to the yield of seromycin;Together When avoid a large amount of uses of PCl5 or acyl chlorides reagent in the synthetic technology of existing seromycin, it is more environmentally-friendly;End process, mistake Salt is filtered off, is concentrated to get product, process is simple, is easier to industrialize, and final products purity is up to 99%, and yield is up to 94.72%.
Specific embodiment
Combined with specific embodiments below the present invention is made further to explain.
Embodiment 1
1) 105gD- serine is added to paraformaldehyde 108g in 500ml tetrahydrofuran, is reacted at room temperature 2 hours, recycling Tetrahydrofuran crystallizes to obtain D-Ser NCA to small size;
2) in methyl alcohol, 110ml thionyl chloride is added in D-Ser NCA, and 15 DEG C are reacted 1 hour, and recycling methanol is added 300mL petroleum ether obtains R-3- chlorine serine methyl ester hydrochloride;(obtaining product R-3- chlorine serine methyl ester hydrochloride quality is 160.92g, purity 99.421%, yield 91.93%).
Embodiment 2
1) 105gD- serine is added to paraformaldehyde 126g in 500ml tetrahydrofuran, is reacted at room temperature 0.5 hour, is returned Tetrahydrofuran is received, crystallizes to obtain D-Ser NCA to small size;
2) in methyl alcohol, 130ml thionyl chloride is added in D-Ser NCA, and 20 DEG C are reacted 3 hours, and recycling methanol is added 300mL petroleum ether obtains R-3- chlorine serine methyl ester hydrochloride;(obtaining product R-3- chlorine serine methyl ester hydrochloride quality is 166.87g, purity 99.488%, yield 93.11%).
Embodiment 3
1) 105gD- serine is added to paraformaldehyde 135g in 500ml tetrahydrofuran, is reacted at room temperature 3 hours, recycling Tetrahydrofuran crystallizes to obtain D-Ser NCA to small size;
2) in methyl alcohol, 145ml thionyl chloride is added in D-Ser NCA, and 25 DEG C are reacted 2 hours, and recycling methanol is added 300mL petroleum ether obtains R-3- chlorine serine methyl ester hydrochloride;(obtaining product R-3- chlorine serine methyl ester hydrochloride quality is 165.63g, purity 99.526%, yield 94.72%).

Claims (5)

1. a kind of synthetic method of R-3- chlorine serine methyl ester hydrochloride, which is characterized in that method and step is as follows:
1) synthesis of D-Ser-N- carboxy acid anhydride: paraformaldehyde is added in D-Ser in a solvent, reacts at room temperature 0.5-3 Hour, recycling design crystallizes to obtain D-Ser-N- carboxy acid anhydride to small size;
2) synthesis of R-3- chlorine serine methyl ester hydrochloride: D-Ser NCA is added in a solvent, and thionyl chloride, 15-25 is added DEG C reaction 1-3 hour, after recycling design, addition petroleum ether crystallize to obtain R-3- chlorine serine methyl ester hydrochloride.
2. a kind of synthetic method of R-3- chlorine serine methyl ester hydrochloride according to claim 1, which is characterized in that described The molar ratio of D-Ser and paraformaldehyde is 1:1.2-1.5 in reaction.
3. a kind of synthetic method of R-3- chlorine serine methyl ester hydrochloride according to claim 1, which is characterized in that described The molar ratio of D-Ser NCA and thionyl chloride and petroleum ether is 1:1.5-2.0:1 in reaction.
4. a kind of synthetic method of R-3- chlorine serine methyl ester hydrochloride according to claim 1, which is characterized in that step 1) solvent is anhydrous tetrahydro furan or methylene chloride.
5. a kind of synthetic method of R-3- chlorine serine methyl ester hydrochloride according to claim 1, which is characterized in that step 2) solvent is methanol or ethyl alcohol.
CN201811613850.3A 2018-12-27 2018-12-27 Synthetic method of R-3-chloroserine methyl ester hydrochloride Active CN109678739B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201811613850.3A CN109678739B (en) 2018-12-27 2018-12-27 Synthetic method of R-3-chloroserine methyl ester hydrochloride
PCT/CN2019/103059 WO2020134137A1 (en) 2018-12-27 2019-08-28 Method for synthesizing r-3-chloroalanine methyl ester hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811613850.3A CN109678739B (en) 2018-12-27 2018-12-27 Synthetic method of R-3-chloroserine methyl ester hydrochloride

Publications (2)

Publication Number Publication Date
CN109678739A true CN109678739A (en) 2019-04-26
CN109678739B CN109678739B (en) 2020-05-05

Family

ID=66190633

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811613850.3A Active CN109678739B (en) 2018-12-27 2018-12-27 Synthetic method of R-3-chloroserine methyl ester hydrochloride

Country Status (2)

Country Link
CN (1) CN109678739B (en)
WO (1) WO2020134137A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110590587A (en) * 2019-09-23 2019-12-20 湖北宇阳药业有限公司 Synthetic method of 3-chloro-L-alanine methyl ester hydrochloride
CN110606811A (en) * 2019-09-23 2019-12-24 湖北宇阳药业有限公司 Synthetic method of L-serine methyl ester hydrochloride

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3936469A (en) * 1972-11-13 1976-02-03 Kyowa Hakko Kogyo Kabushiki Kaisha Process for preparing N-carboxylic anhydrides of amino acids
CN104003894A (en) * 2013-02-21 2014-08-27 浙江嘉华化工有限公司 Method for preparing N-acetyl-beta-chlorine-L-alanine methyl ester

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106518694A (en) * 2016-10-24 2017-03-22 浙江金伯士药业有限公司 Novel preparation method of L-alanine isopropyl ester hydrochloride
CN106518695A (en) * 2016-11-03 2017-03-22 安徽省诚联医药科技有限公司 A synthetic method of (R)-methyl 2-amino-3-chloropropanoate hydrochloride

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3936469A (en) * 1972-11-13 1976-02-03 Kyowa Hakko Kogyo Kabushiki Kaisha Process for preparing N-carboxylic anhydrides of amino acids
CN104003894A (en) * 2013-02-21 2014-08-27 浙江嘉华化工有限公司 Method for preparing N-acetyl-beta-chlorine-L-alanine methyl ester

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LAPIDOT, Y.等: "Reaction of phosgene with serine and ethanolamine", 《ISRAEL JOURNAL OF CHEMISTRY》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110590587A (en) * 2019-09-23 2019-12-20 湖北宇阳药业有限公司 Synthetic method of 3-chloro-L-alanine methyl ester hydrochloride
CN110606811A (en) * 2019-09-23 2019-12-24 湖北宇阳药业有限公司 Synthetic method of L-serine methyl ester hydrochloride
CN110606811B (en) * 2019-09-23 2022-12-02 湖北宇阳药业有限公司 Synthetic method of L-serine methyl ester hydrochloride

Also Published As

Publication number Publication date
CN109678739B (en) 2020-05-05
WO2020134137A1 (en) 2020-07-02

Similar Documents

Publication Publication Date Title
CN109678739A (en) A kind of synthetic method of R-3- chlorine serine methyl ester hydrochloride
CN110878032B (en) Synthesis method of N-benzylacetamidine hydrochloride
CN114057594A (en) Process for preparing 2-amino-N- (2,2, 2-trifluoroethyl) acetamide or its salt
CN101979376B (en) Method for preparing glycinamide hydrochloride
CN101260381B (en) Engineering bacterium, construction thereof and method for preparing D-valine by using the same
CN101891645A (en) Method for preparing salicylamide
CN101333175A (en) Method for preparing D-asparagine and D-homoserine
CN107011190A (en) A kind of 1,2 7-oxa-bicyclo[4.1.0 open loop prepares the new technology of β aminocyclohexanols
CN105566257A (en) Industrial preparation method of acetyl tetrahydrofuran with high optical purity
CN102304102B (en) Preparation method of 1-methyl piperazine
CN112266364B (en) Preparation method of tetrahydroquinoxaline compound
CN112552184B (en) Synthetic method of cyclopropyl-containing chiral amine hydrochloride
CN110684028B (en) Preparation method of 2, 6-diazabicyclo [3,3,0] octane compound
CN103351386A (en) Synthetic method of azasetron hydrochloride
CN109734680A (en) A kind of D-Cycloserine synthetic method
CN105198825B (en) A kind of preparation method of D seromycins
CN111848535A (en) Process for synthesizing 1H-tetrazole acetic acid
CN102351733B (en) Method for preparing 2-amino-dimethyl acetamide hydrochloride
CN109111371B (en) Preparation method of hydrazino ethyl acetate hydrochloride
CN101525641A (en) Method for producing L-tryptophan by microbial enzyme method
CN113636980B (en) Preparation method of dexrazoxane
CN110845356B (en) Synthesis method of hydrazino ethyl acetate hydrochloride
CN101250116B (en) Method for suppressing impurity substance during preparation of benzo ammonia alcohol
CN114957288B (en) Synthesis method of tetramisole hydrochloride
CN116621838A (en) Butterfly acid active ester and synthesis method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: Room 2708, 27th floor, No. 4 Huixin East Street, Chaoyang District, Beijing

Applicant after: Beijing Fusheng Jiahua Pharmaceutical Technology Co., Ltd.

Address before: Room 2708, 27th floor, No. 4 Huixin East Street, Chaoyang District, Beijing

Applicant before: Beijing Fusheng Jiahua International Trade Co., Ltd.

CB02 Change of applicant information
GR01 Patent grant
GR01 Patent grant
CB03 Change of inventor or designer information

Inventor after: Liu Lili

Inventor after: Yuan Zhifa

Inventor after: Wang Dan

Inventor after: Yang Wen

Inventor after: Li Jun

Inventor after: Zhang Xinwei

Inventor before: Wang Dan

Inventor before: Yang Wen

Inventor before: Li Jun

Inventor before: Zhang Xinwei

Inventor before: Liu Lili

Inventor before: Yuan Zhifa

CB03 Change of inventor or designer information